VolitionRx Limited is a multi-national epigenetics company that develops blood-based diagnostic tests for cancer detection and monitoring, as well as diseases associated with NETosis. The company's portfolio includes Nu.Q Vet, a cancer screening test for veterinary applications; Nu.Q Nets, which detects conditions related to NETosis such as sepsis; Nu.Q Discover, a nucleosome profiling solution; and Nu.Q Cancer, designed to predict treatment response, monitor disease progression, and inform treatment adjustments. The company also offers Capture-PCR and Capture-Seq technologies for isolating circulating tumor-derived DNA from plasma samples to support early cancer detection.
VolitionRx operates across the United States, Europe, and Asia. The company employs approximately 75 full-time staff and maintains headquarters in Henderson, Nevada. Its diagnostic tests target multiple applications within oncology and infectious disease management, positioning the company across both clinical cancer care and broader diagnostic segments.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.31 | — | — | |
| 2023 | — | — | — | |
| 2022 | — | — | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — | |
| 2014 | — | — | — | |
| 2013 | — | — | — | |
| 2012 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-31 | 0001477932-25-002231 | SEC ↗ |
| 2023-12-31 | 2024-03-25 | 0001477932-24-001453 | SEC ↗ |
| 2022-12-31 | 2023-03-15 | 0001477932-23-001497 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0001477932-22-001740 | SEC ↗ |
| 2020-12-31 | 2021-03-22 | 0001078782-21-000262 | SEC ↗ |
| 2019-12-31 | 2020-02-20 | 0001078782-20-000134 | SEC ↗ |
| 2018-12-31 | 2019-03-13 | 0001078782-19-000220 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001078782-18-000250 | SEC ↗ |
| 2016-12-31 | 2017-03-10 | 0001078782-17-000302 | SEC ↗ |
| 2015-12-31 | 2016-03-11 | 0001078782-16-002414 | SEC ↗ |
| 2014-12-31 | 2015-03-18 | 0001078782-15-000395 | SEC ↗ |
| 2013-12-31 | 2014-03-28 | 0001078782-14-000481 | SEC ↗ |
| 2012-12-31 | 2013-04-01 | 0001078782-13-000597 | SEC ↗ |
| 2011-08-31 | 2011-11-29 | 0001078782-11-003459 | SEC ↗ |